Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
作者信息
Lane Deirdre A, Wood Kathryn
机构信息
From University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom (D.A.L.); Duke University School of Nursing, Durham, NC (K.W.).
出版信息
Circulation. 2015 Apr 21;131(16):e412-5. doi: 10.1161/CIRCULATIONAHA.114.012808.
Abstract
摘要
相似文献
1
Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.心脏病患者页面。心房颤动患者服用非维生素K拮抗剂口服抗凝剂的指南。
Circulation. 2015 Apr 21;131(16):e412-5. doi: 10.1161/CIRCULATIONAHA.114.012808.
2
[New clinical perspectives in the management of oral direct anticoagulant agents].[口服直接抗凝剂管理的新临床视角]
Med Clin (Barc). 2014 Feb 20;142(4):171-8. doi: 10.1016/j.medcli.2013.05.002. Epub 2013 Jul 16.
3
New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.新型口服抗凝剂：处方、实验室检测及围手术期/出血管理实用指南。澳大利亚血栓与止血学会。
Intern Med J. 2014 Jun;44(6):525-36. doi: 10.1111/imj.12448.
4
[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].[新型口服抗凝药——华法林在房颤治疗中的落幕]
Kardiol Pol. 2012;70(10):1053-60.
5
[New oral anticoagulants in venous thromboembolism. General practice information on switching, monitoring, pausing].[新型口服抗凝药用于静脉血栓栓塞症。关于转换、监测、暂停用药的全科医学信息]
MMW Fortschr Med. 2015 Jan 19;157(1):24. doi: 10.1007/s15006-015-2575-7.
6
Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.直接口服抗凝剂治疗急性静脉血栓栓塞症：系统评价和荟萃分析。
Thromb Res. 2014 Oct;134(4):774-82. doi: 10.1016/j.thromres.2014.06.020. Epub 2014 Jul 6.
7
8
Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.用于心房颤动患者预防卒中的新型口服抗凝药。
Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006.
9
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.新型口服抗凝药物在预防心房颤动卒中方面的疗效和安全性的间接比较。
J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9.
10
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis.依度沙班与达比加群、利伐沙班及阿哌沙班相比在预防心房颤动患者卒中方面的疗效和安全性：一项间接比较分析
Thromb Haemost. 2014 May 5;111(5):981-8. doi: 10.1160/TH14-02-0118. Epub 2014 Feb 28.
引用本文的文献
1
The Effect of Direct Oral Anticoagulants on Gastric Mucosa and Helicobacter Pylori Prevalence in Dyspeptic Patients: A Retrospective Cross-Sectional Study.直接口服抗凝剂对消化不良患者胃黏膜及幽门螺杆菌感染率的影响：一项回顾性横断面研究
Cureus. 2023 Oct 4;15(10):e46477. doi: 10.7759/cureus.46477. eCollection 2023 Oct.
2
Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?失代偿期肝硬化患者心房颤动的抗凝治疗：大胆且勇敢？
Diagnostics (Basel). 2023 Mar 18;13(6):1160. doi: 10.3390/diagnostics13061160.
3
Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?低抗凝强度的华法林或利伐沙班能否为亚洲房颤患者带来生存获益？
Front Cardiovasc Med. 2021 Nov 25;8:768730. doi: 10.3389/fcvm.2021.768730. eCollection 2021.
4
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life.心房颤动患者的胃肠道出血与直接口服抗凝剂：风险、预防、管理及生活质量
TH Open. 2021 Jun 16;5(2):e200-e210. doi: 10.1055/s-0041-1730035. eCollection 2021 Apr.
5
Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data.不同抗栓治疗方案的出血风险特征：来自上市后监测数据的真实世界分析证据。
Cardiovasc Drugs Ther. 2022 Feb;36(1):103-112. doi: 10.1007/s10557-020-07110-w. Epub 2020 Nov 23.
6
Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis.新型口服抗凝剂胃肠道安全性概况的差异：网状Meta分析证据
Clin Epidemiol. 2019 Oct 1;11:911-921. doi: 10.2147/CLEP.S219335. eCollection 2019.
7
Development and validation of a questionnaire to self-assess patient knowledge of direct oral anticoagulants (KODOA-test).直接口服抗凝剂患者知识自我评估问卷（KODOA测试）的开发与验证
Drug Healthc Patient Saf. 2018 Jul 20;10:69-77. doi: 10.2147/DHPS.S152954. eCollection 2018.
Zotero 插件